Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Synthetic immune niches for cancer immunotherapy.
Weiden J, Tel J, Figdor CG. Weiden J, et al. Among authors: tel j. Nat Rev Immunol. 2018 Mar;18(3):212-219. doi: 10.1038/nri.2017.89. Epub 2017 Aug 30. Nat Rev Immunol. 2018. PMID: 28853444 Review.
Affinity-Based Purification of Polyisocyanopeptide Bioconjugates.
Hammink R, Eggermont LJ, Zisis T, Tel J, Figdor CG, Rowan AE, Blank KG. Hammink R, et al. Among authors: tel j. Bioconjug Chem. 2017 Oct 18;28(10):2560-2568. doi: 10.1021/acs.bioconjchem.7b00398. Epub 2017 Sep 15. Bioconjug Chem. 2017. PMID: 28846388
Tumoricidal activity of human dendritic cells.
Tel J, Anguille S, Waterborg CE, Smits EL, Figdor CG, de Vries IJ. Tel J, et al. Trends Immunol. 2014 Jan;35(1):38-46. doi: 10.1016/ Epub 2013 Nov 18. Trends Immunol. 2014. PMID: 24262387 Free PMC article. Review.
Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery.
Weiden J, Voerman D, Dölen Y, Das RK, van Duffelen A, Hammink R, Eggermont LJ, Rowan AE, Tel J, Figdor CG. Weiden J, et al. Among authors: tel j. Front Immunol. 2018 Nov 28;9:2798. doi: 10.3389/fimmu.2018.02798. eCollection 2018. Front Immunol. 2018. PMID: 30546367 Free PMC article.
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.
Dölen Y, Kreutz M, Gileadi U, Tel J, Vasaturo A, van Dinther EA, van Hout-Kuijer MA, Cerundolo V, Figdor CG. Dölen Y, et al. Oncoimmunology. 2015 Aug 12;5(1):e1068493. doi: 10.1080/2162402X.2015.1068493. eCollection 2016. Oncoimmunology. 2015. PMID: 26942088 Free PMC article.
Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect.
Hammink R, Mandal S, Eggermont LJ, Nooteboom M, Willems PH, Tel J, Rowan AE, Figdor CG, Blank KG. Hammink R, et al. ACS Omega. 2017 Mar 31;2(3):937-945. doi: 10.1021/acsomega.6b00436. Epub 2017 Mar 16. ACS Omega. 2017. PMID: 28393131 Free PMC article.
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells.
Schreibelt G, Bol KF, Westdorp H, Wimmers F, Aarntzen EH, Duiveman-de Boer T, van de Rakt MW, Scharenborg NM, de Boer AJ, Pots JM, Olde Nordkamp MA, van Oorschot TG, Tel J, Winkels G, Petry K, Blokx WA, van Rossum MM, Welzen ME, Mus RD, Croockewit SA, Koornstra RH, Jacobs JF, Kelderman S, Blank CU, Gerritsen WR, Punt CJ, Figdor CG, de Vries IJ. Schreibelt G, et al. Clin Cancer Res. 2016 May 1;22(9):2155-66. doi: 10.1158/1078-0432.CCR-15-2205. Epub 2015 Dec 28. Clin Cancer Res. 2016. PMID: 26712687 Clinical Trial.
49 results
Jump to page